Pharmafile Logo

oral minoxidil

- PMLiVE

Veradermics announces phase 3 results for oral minoxidil for hair loss

If approved, it would be the only FDA-approved, oral, non-hormonal treatment for pattern hair loss in both male and female patients

- PMLiVE

Veradermics’ oral treatment for female pattern hair loss delivers positive study results

Pattern hair loss affects around 30 million women and 50 million men in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links